Anil Potti
Duke Medical Center(US)Cellular Therapeutics (United Kingdom)(GB)Duke University Hospital(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Gene expression and cancer classification, Chronic Lymphocytic Leukemia Research, HER2/EGFR in Cancer Research
Most-Cited Works
- → Oncogenic pathway signatures in human cancers as a guide to targeted therapies(2005)2,062 cited
- → Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression(2008)900 cited
- → Genomic signatures to guide the use of chemotherapeutics(2006)593 cited
- → A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer(2006)577 cited
- → A pathway-based classification of human breast cancer(2010)332 cited
- → Expression of Concern: Up‐regulation of Wnt‐1 and β‐catenin production in patients with advanced metastatic prostate carcinoma(2004)283 cited
- → An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer